Bomiao Hu
机构：China Jiliang University · ORCID：0009-0001-4697-0577
发表论文 83 篇 · 总被引 611 次 · h-index 3
代表论文
- Epigenetic priming promotes tyrosine kinase inhibitor resistance and oncogene amplification (2025 · Nature Structural & Molecular Biology · 被引 3)
- Epigenetic priming promotes acquisition of tyrosine kinase inhibitor resistance and oncogene amplification in human lung cancer (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 2)
- Amplitude and phase control of double-sided metal metasurface microstructure (2026 · Laser Physics Letters)
- Table S3 from ASCL1 Drives Tolerance to Osimertinib in <i>EGFR</i> Mutant Lung Cancer in Permissive Cellular Contexts (2024)
- Figure S4 from ASCL1 Drives Tolerance to Osimertinib in <i>EGFR</i> Mutant Lung Cancer in Permissive Cellular Contexts (2024)
- Figure S1 from ASCL1 Drives Tolerance to Osimertinib in <i>EGFR</i> Mutant Lung Cancer in Permissive Cellular Contexts (2024)